{"entity":{"type":"insider","cik":"0001478521","url":"/insider/0001478521","json_url":"/insider/0001478521.json","name":"Higgins Michael J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2011-06-28","last":"2022-07-18","span_basis":"filed_date"},"name_variants":[{"name":"Higgins Michael J","source":"filing","n_filings":7,"first_seen":"2011-06-28","last_seen":"2022-07-18"}],"transactions":[{"id":6648666,"accession":"0001104659-22-080576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-080576","line_url":"/filing/0001104659-22-080576#line-1","is_derivative":false,"issuer_cik":"0001478521","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001478521","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13891.0,"shares_display":"13,891","price_per_share":6.7,"price_display":"6.70","price_state":"stated","total_value":93069.7,"total_display":"93,069.70","total_whole":"93,070","shares_owned_after":31314.0,"shares_owned_after_display":"31,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-14","filed_date":"2022-07-18","scope":"insider"},{"id":6297883,"accession":"0001209191-14-076647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-076647","line_url":"/filing/0001209191-14-076647#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15987.0,"shares_display":"15,987","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":223977.87,"total_display":"223,977.87","total_whole":"223,978","shares_owned_after":300000.0,"shares_owned_after_display":"300,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-18","scope":"insider"},{"id":7035780,"accession":"0001209191-14-071540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-071540","line_url":"/filing/0001209191-14-071540#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70898.0,"shares_display":"70,898","price_per_share":13.75,"price_display":"13.75","price_state":"stated","total_value":974847.5,"total_display":"974,847.50","total_whole":"974,848","shares_owned_after":300000.0,"shares_owned_after_display":"300,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-26","scope":"insider"},{"id":6911714,"accession":"0001209191-14-038045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-038045","line_url":"/filing/0001209191-14-038045#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.56,"price_display":"14.56","price_state":"stated","total_value":728000.0,"total_display":"728,000.00","total_whole":"728,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-29","filed_date":"2014-05-30","scope":"insider"},{"id":4304395,"accession":"0001209191-13-032699","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-032699","line_url":"/filing/0001209191-13-032699#line-6","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5900.0,"shares_display":"5,900","price_per_share":11.84,"price_display":"11.84","price_state":"stated","total_value":69856.0,"total_display":"69,856.00","total_whole":"69,856","shares_owned_after":266666.0,"shares_owned_after_display":"266,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-18","scope":"insider"},{"id":4304376,"accession":"0001209191-13-032699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-032699","line_url":"/filing/0001209191-13-032699#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144100.0,"shares_display":"144,100","price_per_share":11.74,"price_display":"11.74","price_state":"stated","total_value":1691734.0,"total_display":"1,691,734.00","total_whole":"1,691,734","shares_owned_after":241666.0,"shares_owned_after_display":"241,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-18","scope":"insider"},{"id":5037292,"accession":"0001209191-13-014971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-014971","line_url":"/filing/0001209191-13-014971#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":15.57,"price_display":"15.57","price_state":"stated","total_value":778500.0,"total_display":"778,500.00","total_whole":"778,500","shares_owned_after":141666.0,"shares_owned_after_display":"141,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-07","scope":"insider"},{"id":9096282,"accession":"0001209191-11-036590","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-036590","line_url":"/filing/0001209191-11-036590#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478521","owner_name":"Higgins Michael J","owner_display_name":"Higgins Michael J","owner_url":"/insider/0001478521","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.94,"price_display":"15.94","price_state":"stated","total_value":398500.0,"total_display":"398,500.00","total_whole":"398,500","shares_owned_after":125000.0,"shares_owned_after_display":"125,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-24","filed_date":"2011-06-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640266","name":"Voyager Therapeutics, Inc.","url":"/issuer/0001640266","role":"Director","n_filings":1,"first_seen":"2022-07-18","last_seen":"2022-07-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (Chief Operating Officer)","n_filings":6,"first_seen":"2011-06-28","last_seen":"2014-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001478521","retrieved_at":"2026-08-23T14:07:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}